A randomized phase III trial of Paraplatin (carboplatin) + Gemzar [gemcitabine] versus Gemzar alone in patients wtih advanced non-small cell lung cancer

Trial Profile

A randomized phase III trial of Paraplatin (carboplatin) + Gemzar [gemcitabine] versus Gemzar alone in patients wtih advanced non-small cell lung cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2009

At a glance

  • Drugs Carboplatin; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Nov 2009 Results published in the Journal of Clinical Oncology.
    • 10 Nov 2007 Status change from in progress to completed.
    • 19 Jan 2007 Status changed from recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top